Exchange: NYSE·Updated 02:58 PM EDT
DGX logo

DGXQuest Diagnostics, Inc.

$216.10
$4.15
(1.96%)
Today
EarningsJul 23
Mkt Cap$23.46B
Vol441,312.00
News
all
press releases
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
Here is how Coya Therapeutics, Inc. (COYA) and Quest Diagnostics (DGX) have performed compared to their sector so far this year.
Zacks
News Placeholder
More News
News Placeholder
How Abbott's Largest Segment Is Preparing for the Next Growth Phase
ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 2026.
Zacks
News Placeholder
DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH
Quest Diagnostics gains NYSDOH approval for Haystack MRD, expanding the cancer test to all 50 states and strengthening its oncology reach.
Zacks
News Placeholder
Quest Diagnostics Receives New York State Approval for Haystack MRD, Broadening Patient Access to ctDNA Minimal Residual Disease Testing
Quest Diagnostics Receives New York State Approval for Haystack MRD, Broadening Patient Access to ctDNA Minimal Residual Disease Testing Quest Diagnostics Receives New York State Approval for Haystack MRD, Broadening Patient Access to ctDNA Minimal Residual Disease Testing PR Newswire SECAUCUS...
PR Newswire
News Placeholder
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?
DGX gains from Advanced Diagnostics, physician and consumer testing growth, plus AI-driven efficiency efforts, even as debt and policy risks linger.
Zacks
News Placeholder
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics
UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics PR Newswire SECAUCUS, N.J., June 18, 2026 Published in Nature...
PR Newswire
News Placeholder
Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026 Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026 PR Newswire SECAUCUS, N.J., June 17, 2026 SECAUCUS, N.J., June 17, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader...
PR Newswire
News Placeholder
Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report
Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.